Gal-3, which increases endothelial dysfunction and is produced systemically from fibroblasts and macrophages during active inflammation, is a marker of HF, coronary heart disease (CHD), and cardiovascular fibrosis [35,39]. This evidence concerns the gene LGALS3 and coronary artery disorder.